FGF1 and inflammatory bowel disease: Subsequently, upregulation of FGF-1 was described in allografts undergoing chronic rejection [38] and in renal inflammation [39], while elevated levels of circulating FGF-2 were reported in patients with inflammatory bowel disease [40] and eosinophilic esophagitis [41].